Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 39% ± 19% | |
pericyte | 7 studies | 30% ± 8% | |
GABAergic neuron | 7 studies | 32% ± 12% | |
endothelial cell | 6 studies | 34% ± 14% | |
interneuron | 6 studies | 38% ± 13% | |
smooth muscle cell | 6 studies | 29% ± 9% | |
fibroblast | 5 studies | 38% ± 12% | |
neuron | 4 studies | 21% ± 4% | |
astrocyte | 4 studies | 43% ± 20% | |
retina horizontal cell | 4 studies | 53% ± 14% | |
retinal rod cell | 4 studies | 45% ± 16% | |
GABAergic interneuron | 3 studies | 24% ± 7% | |
microglial cell | 3 studies | 51% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3600.08 | 245 / 245 | 96% | 21.36 | 483 / 502 |
thymus | 100% | 2936.58 | 651 / 653 | 71% | 4.80 | 431 / 605 |
bladder | 100% | 1791.14 | 21 / 21 | 39% | 2.11 | 197 / 504 |
breast | 94% | 688.03 | 431 / 459 | 44% | 4.52 | 487 / 1118 |
pancreas | 48% | 183.60 | 158 / 328 | 88% | 13.07 | 156 / 178 |
intestine | 87% | 779.78 | 841 / 966 | 35% | 2.55 | 186 / 527 |
uterus | 98% | 1074.96 | 166 / 170 | 24% | 3.18 | 109 / 459 |
esophagus | 77% | 789.13 | 1114 / 1445 | 42% | 2.39 | 76 / 183 |
lung | 72% | 387.93 | 418 / 578 | 45% | 3.72 | 519 / 1155 |
brain | 45% | 157.77 | 1192 / 2642 | 71% | 5.23 | 498 / 705 |
stomach | 63% | 412.00 | 226 / 359 | 52% | 5.10 | 150 / 286 |
adipose | 100% | 1042.39 | 1198 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 1657.06 | 1314 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 950.67 | 822 / 861 | 0% | 0 | 0 / 0 |
liver | 53% | 212.81 | 120 / 226 | 33% | 2.45 | 134 / 406 |
ovary | 74% | 405.34 | 133 / 180 | 7% | 0.40 | 28 / 430 |
kidney | 21% | 58.72 | 19 / 89 | 58% | 6.92 | 523 / 901 |
skin | 33% | 128.87 | 595 / 1809 | 45% | 7.07 | 213 / 472 |
adrenal gland | 7% | 19.51 | 18 / 258 | 44% | 3.39 | 102 / 230 |
tonsil | 0% | 0 | 0 / 0 | 42% | 2.78 | 19 / 45 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.79 | 6 / 29 |
muscle | 17% | 57.73 | 139 / 803 | 0% | 0 | 0 / 0 |
spleen | 10% | 27.27 | 23 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
peripheral blood | 0% | 0.49 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0045806 | Biological process | negative regulation of endocytosis |
GO_0007155 | Biological process | cell adhesion |
GO_0097156 | Biological process | fasciculation of motor neuron axon |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0043087 | Biological process | regulation of GTPase activity |
GO_0051893 | Biological process | regulation of focal adhesion assembly |
GO_0070507 | Biological process | regulation of microtubule cytoskeleton organization |
GO_0006468 | Biological process | protein phosphorylation |
GO_0010717 | Biological process | regulation of epithelial to mesenchymal transition |
GO_0097155 | Biological process | fasciculation of sensory neuron axon |
GO_0016477 | Biological process | cell migration |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0007411 | Biological process | axon guidance |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005004 | Molecular function | GPI-linked ephrin receptor activity |
GO_0005003 | Molecular function | ephrin receptor activity |
GO_0005005 | Molecular function | transmembrane-ephrin receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EPHA3 |
Protein name | Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1) receptor protein-tyrosine kinase (EC 2.7.10.1) Ephrin type-A receptor 3 variant (EC 2.7.10.1) |
Synonyms | HEK hCG_33008 ETK ETK1 TYRO4 |
Description | FUNCTION: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Highly promiscuous for ephrin-A ligands it binds preferentially EFNA5. Upon activation by EFNA5 regulates cell-cell adhesion, cytoskeletal organization and cell migration. Plays a role in cardiac cells migration and differentiation and regulates the formation of the atrioventricular canal and septum during development probably through activation by EFNA1. Involved in the retinotectal mapping of neurons. May also control the segregation but not the guidance of motor and sensory axons during neuromuscular circuit development. . |
Accessions | P29320 Q6P4R6 ENST00000494014.1 E2I6F6 A0A140VJJ0 C9JXA2 ENST00000452448.6 [P29320-2] ENST00000336596.7 [P29320-1] |